Filtros : "MONTANARI, CARLOS ALBERTO" "Estados Unidos" "IQSC" Removidos: "Prokopczyk, Igor Muccilo" "Committee of the International Congress of Pharmaceutical Sciences" Limpar

Filtros



Refine with date range


  • Source: Chemical Biology & Drug Design. Unidade: IQSC

    Subjects: BIOQUÍMICA, BIOLOGIA

    Versão PublicadaAcesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Chemical Biology & Drug Design. Chemical Biology & Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://onlinelibrary.wiley.com/page/journal/17470285/homepage/editorialboard.html. Acesso em: 03 out. 2024. , 2024
    • APA

      Chemical Biology & Drug Design. (2024). Chemical Biology & Drug Design. Chemical Biology & Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Recuperado de https://onlinelibrary.wiley.com/page/journal/17470285/homepage/editorialboard.html
    • NLM

      Chemical Biology & Drug Design [Internet]. Chemical Biology & Drug Design. 2024 ;[citado 2024 out. 03 ] Available from: https://onlinelibrary.wiley.com/page/journal/17470285/homepage/editorialboard.html
    • Vancouver

      Chemical Biology & Drug Design [Internet]. Chemical Biology & Drug Design. 2024 ;[citado 2024 out. 03 ] Available from: https://onlinelibrary.wiley.com/page/journal/17470285/homepage/editorialboard.html
  • Source: Chemical Biology and Drug Design. Unidade: IQSC

    Subjects: BIOQUÍMICA, BIOLOGIA

    PrivadoAcesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MELANDER, Roberta e MONTANARI, Carlos Alberto. Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html. Acesso em: 03 out. 2024. , 2023
    • APA

      Melander, R., & Montanari, C. A. (2023). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Recuperado de https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
    • NLM

      Melander R, Montanari CA. Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2023 ;[citado 2024 out. 03 ] Available from: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
    • Vancouver

      Melander R, Montanari CA. Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2023 ;[citado 2024 out. 03 ] Available from: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
  • Source: Chemical Biology and Drug Design. Unidade: IQSC

    Subjects: BIOQUÍMICA, BIOLOGIA

    PrivadoAcesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html. Acesso em: 03 out. 2024. , 2022
    • APA

      Chemical Biology and Drug Design. (2022). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Recuperado de https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
    • NLM

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2022 ;[citado 2024 out. 03 ] Available from: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
    • Vancouver

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2022 ;[citado 2024 out. 03 ] Available from: https://onlinelibrary-wiley.ez67.periodicos.capes.gov.br/page/journal/17470285/homepage/editorialboard.html
  • Source: Journal of Chemical Information and Modeling. Unidade: IQSC

    Subjects: AMINOÁCIDOS, MECÂNICA QUÂNTICA, ENERGIA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANTOS, Alberto M. Dos et al. Assessment of Reversibility for Covalent Cysteine Protease Inhibitors Using Quantum Mechanics/Molecular Mechanics Free Energy Surfaces. Journal of Chemical Information and Modeling, v. 62, p. 4083-4094, 2022Tradução . . Disponível em: https://doi.org/10.1021/acs.jcim.2c00466. Acesso em: 03 out. 2024.
    • APA

      Santos, A. M. D., Oliveira, A. R. S., Costa, C. H. S. da, Kenny, P. W., Montanari, C. A., Varela Júnior, J. de J. G., & Lameira, J. (2022). Assessment of Reversibility for Covalent Cysteine Protease Inhibitors Using Quantum Mechanics/Molecular Mechanics Free Energy Surfaces. Journal of Chemical Information and Modeling, 62, 4083-4094. doi:10.1021/acs.jcim.2c00466
    • NLM

      Santos AMD, Oliveira ARS, Costa CHS da, Kenny PW, Montanari CA, Varela Júnior J de JG, Lameira J. Assessment of Reversibility for Covalent Cysteine Protease Inhibitors Using Quantum Mechanics/Molecular Mechanics Free Energy Surfaces [Internet]. Journal of Chemical Information and Modeling. 2022 ; 62 4083-4094.[citado 2024 out. 03 ] Available from: https://doi.org/10.1021/acs.jcim.2c00466
    • Vancouver

      Santos AMD, Oliveira ARS, Costa CHS da, Kenny PW, Montanari CA, Varela Júnior J de JG, Lameira J. Assessment of Reversibility for Covalent Cysteine Protease Inhibitors Using Quantum Mechanics/Molecular Mechanics Free Energy Surfaces [Internet]. Journal of Chemical Information and Modeling. 2022 ; 62 4083-4094.[citado 2024 out. 03 ] Available from: https://doi.org/10.1021/acs.jcim.2c00466
  • Source: Chemical biology and drug design. Unidade: IQSC

    Subjects: BIOQUÍMICA, BIOLOGIA

    PrivadoHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Chemical biology and drug design. Chemical biology and drug design. Hoboken: Wiley-Blackwell Publishing, Inc. Disponível em: https://repositorio.usp.br/directbitstream/4fe96630-45ee-4a8c-8a14-46a20aa75f89/P19198.pdf. Acesso em: 03 out. 2024. , 2021
    • APA

      Chemical biology and drug design. (2021). Chemical biology and drug design. Chemical biology and drug design. Hoboken: Wiley-Blackwell Publishing, Inc. Recuperado de https://repositorio.usp.br/directbitstream/4fe96630-45ee-4a8c-8a14-46a20aa75f89/P19198.pdf
    • NLM

      Chemical biology and drug design [Internet]. Chemical biology and drug design. 2021 ;[citado 2024 out. 03 ] Available from: https://repositorio.usp.br/directbitstream/4fe96630-45ee-4a8c-8a14-46a20aa75f89/P19198.pdf
    • Vancouver

      Chemical biology and drug design [Internet]. Chemical biology and drug design. 2021 ;[citado 2024 out. 03 ] Available from: https://repositorio.usp.br/directbitstream/4fe96630-45ee-4a8c-8a14-46a20aa75f89/P19198.pdf
  • Source: Journal of Chemical Information and Modeling. Unidade: IQSC

    Subjects: MEDICAMENTO, ENZIMAS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BONATTO, Vinícius et al. Predicting the Relative Binding Affinity for Reversible Covalent Inhibitors by Free Energy Perturbation Calculations. Journal of Chemical Information and Modeling, v. 61, p. 4733−4744, 2021Tradução . . Disponível em: https://doi.org/10.1021/acs.jcim.1c00515. Acesso em: 03 out. 2024.
    • APA

      Bonatto, V., Shamim, A., Rocho, F. dos R., Leitão, A., Luque, F. J., & Montanari, C. A. (2021). Predicting the Relative Binding Affinity for Reversible Covalent Inhibitors by Free Energy Perturbation Calculations. Journal of Chemical Information and Modeling, 61, 4733−4744. doi:10.1021/acs.jcim.1c00515
    • NLM

      Bonatto V, Shamim A, Rocho F dos R, Leitão A, Luque FJ, Montanari CA. Predicting the Relative Binding Affinity for Reversible Covalent Inhibitors by Free Energy Perturbation Calculations [Internet]. Journal of Chemical Information and Modeling. 2021 ; 61 4733−4744.[citado 2024 out. 03 ] Available from: https://doi.org/10.1021/acs.jcim.1c00515
    • Vancouver

      Bonatto V, Shamim A, Rocho F dos R, Leitão A, Luque FJ, Montanari CA. Predicting the Relative Binding Affinity for Reversible Covalent Inhibitors by Free Energy Perturbation Calculations [Internet]. Journal of Chemical Information and Modeling. 2021 ; 61 4733−4744.[citado 2024 out. 03 ] Available from: https://doi.org/10.1021/acs.jcim.1c00515
  • Source: Journal of Chemical Information and Modeling. Unidade: IQSC

    Assunto: QUÍMICA MÉDICA

    PrivadoAcesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      COSTA, Clauber H. S et al. Evaluating QM/MM Free Energy Surfaces for Ranking Cysteine Protease Covalent Inhibitors. Journal of Chemical Information and Modeling, p. 880-889, 2020Tradução . . Disponível em: https://doi.org/10.1021/acs.jcim.9b00847. Acesso em: 03 out. 2024.
    • APA

      Costa, C. H. S., Bonatto, V., Santos, A. M. dos, Lameira, J., Leitão, A., & Montanari, C. A. (2020). Evaluating QM/MM Free Energy Surfaces for Ranking Cysteine Protease Covalent Inhibitors. Journal of Chemical Information and Modeling, 880-889. doi:10.1021/acs.jcim.9b00847
    • NLM

      Costa CHS, Bonatto V, Santos AM dos, Lameira J, Leitão A, Montanari CA. Evaluating QM/MM Free Energy Surfaces for Ranking Cysteine Protease Covalent Inhibitors [Internet]. Journal of Chemical Information and Modeling. 2020 ; 880-889.[citado 2024 out. 03 ] Available from: https://doi.org/10.1021/acs.jcim.9b00847
    • Vancouver

      Costa CHS, Bonatto V, Santos AM dos, Lameira J, Leitão A, Montanari CA. Evaluating QM/MM Free Energy Surfaces for Ranking Cysteine Protease Covalent Inhibitors [Internet]. Journal of Chemical Information and Modeling. 2020 ; 880-889.[citado 2024 out. 03 ] Available from: https://doi.org/10.1021/acs.jcim.9b00847
  • Source: PLoS Neglected Tropical Diseases. Unidades: IQSC, FCFRP, FMRP

    Assunto: QUÍMICA MÉDICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CIANNI, Lorenzo et al. Mapping the S1 and S1’ subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents. PLoS Neglected Tropical Diseases, v. 14, n. 3, p. 1-36, 2020Tradução . . Disponível em: https://doi.org/10.1371/journal.pntd.0007755. Acesso em: 03 out. 2024.
    • APA

      Cianni, L., Lemke, C., Gilberg, E., Feldmann, C., Rosini, F., Rocho, F. dos R., et al. (2020). Mapping the S1 and S1’ subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents. PLoS Neglected Tropical Diseases, 14( 3), 1-36. doi:10.1371/journal.pntd.0007755
    • NLM

      Cianni L, Lemke C, Gilberg E, Feldmann C, Rosini F, Rocho F dos R, Ribeiro JFR, Tezuka DY, Lopes CD, Albuquerque S de, Bajorath J, Laufer S, Leitão A, Gütschow Michaell, Montanari CA. Mapping the S1 and S1’ subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents [Internet]. PLoS Neglected Tropical Diseases. 2020 ; 14( 3): 1-36.[citado 2024 out. 03 ] Available from: https://doi.org/10.1371/journal.pntd.0007755
    • Vancouver

      Cianni L, Lemke C, Gilberg E, Feldmann C, Rosini F, Rocho F dos R, Ribeiro JFR, Tezuka DY, Lopes CD, Albuquerque S de, Bajorath J, Laufer S, Leitão A, Gütschow Michaell, Montanari CA. Mapping the S1 and S1’ subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents [Internet]. PLoS Neglected Tropical Diseases. 2020 ; 14( 3): 1-36.[citado 2024 out. 03 ] Available from: https://doi.org/10.1371/journal.pntd.0007755
  • Source: Chemical Biology & Drug Design. Unidades: FCFRP, IQSC, FMRP, EESC, ICMC

    Subjects: DOENÇA DE CHAGAS, TRYPANOSOMA CRUZI

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ALBUQUERQUE, Sérgio de et al. Molecular design aided by random forests and synthesis of potent trypanocidal agents as cruzain inhibitors for Chagas disease treatment. Chemical Biology & Drug Design, v. 96, p. 948–960, 2020Tradução . . Disponível em: https://doi.org/10.1111/cbdd.13663. Acesso em: 03 out. 2024.
    • APA

      Albuquerque, S. de, Cianni, L., Vita, D. de, Lopes, C. D., Gomes, A. S. M., Gomes, P., et al. (2020). Molecular design aided by random forests and synthesis of potent trypanocidal agents as cruzain inhibitors for Chagas disease treatment. Chemical Biology & Drug Design, 96, 948–960. doi:10.1111/cbdd.13663
    • NLM

      Albuquerque S de, Cianni L, Vita D de, Lopes CD, Gomes ASM, Gomes P, Laughton C, Leitão A, Montanari CA, Montanari R, Ribeiro JFR, Silva JS da, Teixeira C. Molecular design aided by random forests and synthesis of potent trypanocidal agents as cruzain inhibitors for Chagas disease treatment [Internet]. Chemical Biology & Drug Design. 2020 ; 96 948–960.[citado 2024 out. 03 ] Available from: https://doi.org/10.1111/cbdd.13663
    • Vancouver

      Albuquerque S de, Cianni L, Vita D de, Lopes CD, Gomes ASM, Gomes P, Laughton C, Leitão A, Montanari CA, Montanari R, Ribeiro JFR, Silva JS da, Teixeira C. Molecular design aided by random forests and synthesis of potent trypanocidal agents as cruzain inhibitors for Chagas disease treatment [Internet]. Chemical Biology & Drug Design. 2020 ; 96 948–960.[citado 2024 out. 03 ] Available from: https://doi.org/10.1111/cbdd.13663
  • Source: Experimental Parasitology. Unidades: FCFRP, IQSC, BIOENGENHARIA, EESC

    Assunto: DOENÇA DE CHAGAS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      QUILLES JUNIOR, José Carlos et al. Dipeptidyl nitrile derivatives suppress the Trypanosoma cruzi in vitro infection. Experimental Parasitology, v. 219, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.exppara.2020.108032. Acesso em: 03 out. 2024.
    • APA

      Quilles Junior, J. C., Shamim, A., Tezuka, D. Y., Batista, P. H. J., Lopes, C. D., Albuquerque, S. de, et al. (2020). Dipeptidyl nitrile derivatives suppress the Trypanosoma cruzi in vitro infection. Experimental Parasitology, 219. doi:10.1016/j.exppara.2020.108032
    • NLM

      Quilles Junior JC, Shamim A, Tezuka DY, Batista PHJ, Lopes CD, Albuquerque S de, Montanari CA, Leitão A. Dipeptidyl nitrile derivatives suppress the Trypanosoma cruzi in vitro infection [Internet]. Experimental Parasitology. 2020 ; 219[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.exppara.2020.108032
    • Vancouver

      Quilles Junior JC, Shamim A, Tezuka DY, Batista PHJ, Lopes CD, Albuquerque S de, Montanari CA, Leitão A. Dipeptidyl nitrile derivatives suppress the Trypanosoma cruzi in vitro infection [Internet]. Experimental Parasitology. 2020 ; 219[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.exppara.2020.108032
  • Source: Journal of Chemical Information and Modeling. Unidade: IQSC

    Assunto: DOENÇA DE CHAGAS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, JoséRogerio A. et al. Assessment of the Cruzain Cysteine Protease Reversible and Irreversible Covalent Inhibition Mechanism. Journal of Chemical Information and Modeling, v. 60, n. 3, p. 1666-1677, 2020Tradução . . Disponível em: https://doi.org/10.1021/acs.jcim.9b01138. Acesso em: 03 out. 2024.
    • APA

      Silva, J. R. A., Cianni, L., Araujo, D., Batista, P. H. J., Vita, D. de, Rosini, F., et al. (2020). Assessment of the Cruzain Cysteine Protease Reversible and Irreversible Covalent Inhibition Mechanism. Journal of Chemical Information and Modeling, 60( 3), 1666-1677. doi:10.1021/acs.jcim.9b01138
    • NLM

      Silva JRA, Cianni L, Araujo D, Batista PHJ, Vita D de, Rosini F, Leitão A, Lameira J, Montanari CA. Assessment of the Cruzain Cysteine Protease Reversible and Irreversible Covalent Inhibition Mechanism [Internet]. Journal of Chemical Information and Modeling. 2020 ; 60( 3): 1666-1677.[citado 2024 out. 03 ] Available from: https://doi.org/10.1021/acs.jcim.9b01138
    • Vancouver

      Silva JRA, Cianni L, Araujo D, Batista PHJ, Vita D de, Rosini F, Leitão A, Lameira J, Montanari CA. Assessment of the Cruzain Cysteine Protease Reversible and Irreversible Covalent Inhibition Mechanism [Internet]. Journal of Chemical Information and Modeling. 2020 ; 60( 3): 1666-1677.[citado 2024 out. 03 ] Available from: https://doi.org/10.1021/acs.jcim.9b01138
  • Source: Bioorganic Chemistry. Unidade: IQSC

    Subjects: FÁRMACOS, BIOMARCADORES, PROTEÍNAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CIANNI, Lorenzo et al. Optimization strategy of single-digit nanomolar cross-class inhibitors of mammalian and protozoa cysteine proteases. Bioorganic Chemistry, v. 101, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bioorg.2020.104039. Acesso em: 03 out. 2024.
    • APA

      Cianni, L., Rocho, F. dos R., Rosini, F., Bonatto, V., Ribeiro, J. F. R., Lameira, J., et al. (2020). Optimization strategy of single-digit nanomolar cross-class inhibitors of mammalian and protozoa cysteine proteases. Bioorganic Chemistry, 101. doi:10.1016/j.bioorg.2020.104039
    • NLM

      Cianni L, Rocho F dos R, Rosini F, Bonatto V, Ribeiro JFR, Lameira J, Leitão A, Shamim A, Montanari CA. Optimization strategy of single-digit nanomolar cross-class inhibitors of mammalian and protozoa cysteine proteases [Internet]. Bioorganic Chemistry. 2020 ; 101[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.bioorg.2020.104039
    • Vancouver

      Cianni L, Rocho F dos R, Rosini F, Bonatto V, Ribeiro JFR, Lameira J, Leitão A, Shamim A, Montanari CA. Optimization strategy of single-digit nanomolar cross-class inhibitors of mammalian and protozoa cysteine proteases [Internet]. Bioorganic Chemistry. 2020 ; 101[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.bioorg.2020.104039
  • Source: Chemical biology and drug design. Unidade: IQSC

    Subjects: BIOQUÍMICA, BIOLOGIA

    PrivadoHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Chemical biology and drug design. Chemical biology and drug design. Hoboken: Wiley-Blackwell Publishing, Inc. Disponível em: https://repositorio.usp.br/directbitstream/318f4e8b-f71c-40be-94c5-054d0dd048d1/P18696.pdf. Acesso em: 03 out. 2024. , 2020
    • APA

      Chemical biology and drug design. (2020). Chemical biology and drug design. Chemical biology and drug design. Hoboken: Wiley-Blackwell Publishing, Inc. Recuperado de https://repositorio.usp.br/directbitstream/318f4e8b-f71c-40be-94c5-054d0dd048d1/P18696.pdf
    • NLM

      Chemical biology and drug design [Internet]. Chemical biology and drug design. 2020 ;[citado 2024 out. 03 ] Available from: https://repositorio.usp.br/directbitstream/318f4e8b-f71c-40be-94c5-054d0dd048d1/P18696.pdf
    • Vancouver

      Chemical biology and drug design [Internet]. Chemical biology and drug design. 2020 ;[citado 2024 out. 03 ] Available from: https://repositorio.usp.br/directbitstream/318f4e8b-f71c-40be-94c5-054d0dd048d1/P18696.pdf
  • Source: ACS Infectious Diseases. Unidades: IQSC, FMRP, FCFRP

    Subjects: BIOQUÍMICA, DOENÇA DE CHAGAS

    PrivadoAcesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOPES, Carla Duque et al. Organometallic Gold(III) complex [Au(Hdamp)(L14)]+ (L1 = SNSDonating Thiosemicarbazone) as a candidate to new formulations against Chagas disease. ACS Infectious Diseases, v. 5, n. 10, p. 1698-1707, 2019Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.8b00284. Acesso em: 03 out. 2024.
    • APA

      Lopes, C. D., Possato, B., Gaspari, A. P. S., Oliveira, R. J., Abram, U., Almeida, J. P. A., et al. (2019). Organometallic Gold(III) complex [Au(Hdamp)(L14)]+ (L1 = SNSDonating Thiosemicarbazone) as a candidate to new formulations against Chagas disease. ACS Infectious Diseases, 5( 10), 1698-1707. doi:10.1021/acsinfecdis.8b00284
    • NLM

      Lopes CD, Possato B, Gaspari APS, Oliveira RJ, Abram U, Almeida JPA, Rocho F dos R, Leitão A, Montanari CA, Maia PI da S, Silva JS da, Albuquerque S de, Carneiro ZA. Organometallic Gold(III) complex [Au(Hdamp)(L14)]+ (L1 = SNSDonating Thiosemicarbazone) as a candidate to new formulations against Chagas disease [Internet]. ACS Infectious Diseases. 2019 ; 5( 10): 1698-1707.[citado 2024 out. 03 ] Available from: https://doi.org/10.1021/acsinfecdis.8b00284
    • Vancouver

      Lopes CD, Possato B, Gaspari APS, Oliveira RJ, Abram U, Almeida JPA, Rocho F dos R, Leitão A, Montanari CA, Maia PI da S, Silva JS da, Albuquerque S de, Carneiro ZA. Organometallic Gold(III) complex [Au(Hdamp)(L14)]+ (L1 = SNSDonating Thiosemicarbazone) as a candidate to new formulations against Chagas disease [Internet]. ACS Infectious Diseases. 2019 ; 5( 10): 1698-1707.[citado 2024 out. 03 ] Available from: https://doi.org/10.1021/acsinfecdis.8b00284
  • Source: PLOS ONE. Unidade: IQSC

    Subjects: DOENÇA DE CHAGAS, LIGANTES, PROTEÍNAS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SARTORI, Geraldo Rodrigues et al. Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors. PLOS ONE, v. 14, n. 12, p. e0222055, 2019Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0222055. Acesso em: 03 out. 2024.
    • APA

      Sartori, G. R., Leitão, A., Montanari, C. A., & Laughton, C. A. (2019). Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors. PLOS ONE, 14( 12), e0222055. doi:10.1371/journal.pone.0222055
    • NLM

      Sartori GR, Leitão A, Montanari CA, Laughton CA. Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors [Internet]. PLOS ONE. 2019 ; 14( 12): e0222055.[citado 2024 out. 03 ] Available from: https://doi.org/10.1371/journal.pone.0222055
    • Vancouver

      Sartori GR, Leitão A, Montanari CA, Laughton CA. Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors [Internet]. PLOS ONE. 2019 ; 14( 12): e0222055.[citado 2024 out. 03 ] Available from: https://doi.org/10.1371/journal.pone.0222055
  • Source: Journal of Medicinal Chemistry. Unidade: IQSC

    Assunto: NEOPLASIAS

    PrivadoAcesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CIANNI, Lorenzo et al. Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity?. Journal of Medicinal Chemistry, v. 62, n. 23, p. 10497-10525 july, 2019Tradução . . Disponível em: https://doi.org/10.1021/acs.jmedchem.9b00683. Acesso em: 03 out. 2024.
    • APA

      Cianni, L., Feldmann, C. W., Gilberg, E., Gütschow Michaell,, Juliano, L., Leitão, A., et al. (2019). Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity? Journal of Medicinal Chemistry, 62( 23), 10497-10525 july. doi:10.1021/acs.jmedchem.9b00683
    • NLM

      Cianni L, Feldmann CW, Gilberg E, Gütschow Michaell, Juliano L, Leitão A, Bajorath J, Montanari CA. Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity? [Internet]. Journal of Medicinal Chemistry. 2019 ; 62( 23): 10497-10525 july.[citado 2024 out. 03 ] Available from: https://doi.org/10.1021/acs.jmedchem.9b00683
    • Vancouver

      Cianni L, Feldmann CW, Gilberg E, Gütschow Michaell, Juliano L, Leitão A, Bajorath J, Montanari CA. Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity? [Internet]. Journal of Medicinal Chemistry. 2019 ; 62( 23): 10497-10525 july.[citado 2024 out. 03 ] Available from: https://doi.org/10.1021/acs.jmedchem.9b00683
  • Source: Chemical Biology and Drug Design. Unidade: IQSC

    Subjects: BIOQUÍMICA, BIOLOGIA

    PrivadoHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Disponível em: https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf. Acesso em: 03 out. 2024. , 2019
    • APA

      Chemical Biology and Drug Design. (2019). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Instituto de Química de São Carlos, Universidade de São Paulo. Recuperado de https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf
    • NLM

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2019 ;[citado 2024 out. 03 ] Available from: https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf
    • Vancouver

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2019 ;[citado 2024 out. 03 ] Available from: https://repositorio.usp.br/directbitstream/823d6fdb-0e41-4168-8a43-02c997fca1fc/P17911.pdf
  • Source: Chemical biology and drug design. Unidade: IQSC

    Subjects: BIOQUÍMICA, BIOLOGIA

    PrivadoHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Chemical biology and drug design. Chemical biology and drug design. Hoboken: Wiley-Blackwell Publishing, Inc. Disponível em: https://repositorio.usp.br/directbitstream/4d711067-af92-476d-b1ba-06d809c059dc/P17701.pdf. Acesso em: 03 out. 2024. , 2018
    • APA

      Chemical biology and drug design. (2018). Chemical biology and drug design. Chemical biology and drug design. Hoboken: Wiley-Blackwell Publishing, Inc. Recuperado de https://repositorio.usp.br/directbitstream/4d711067-af92-476d-b1ba-06d809c059dc/P17701.pdf
    • NLM

      Chemical biology and drug design [Internet]. Chemical biology and drug design. 2018 ;[citado 2024 out. 03 ] Available from: https://repositorio.usp.br/directbitstream/4d711067-af92-476d-b1ba-06d809c059dc/P17701.pdf
    • Vancouver

      Chemical biology and drug design [Internet]. Chemical biology and drug design. 2018 ;[citado 2024 out. 03 ] Available from: https://repositorio.usp.br/directbitstream/4d711067-af92-476d-b1ba-06d809c059dc/P17701.pdf
  • Source: Bioorganic Chemistry. Unidade: IQSC

    Subjects: MOLÉCULA, QUÍMICA MÉDICA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CIANNI, Lorenzo et al. Leveraging the cruzain S3 subsite to increase affinity for reversible covalent inhibitors. Bioorganic Chemistry, p. 285-292, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.bioorg.2018.04.006. Acesso em: 03 out. 2024.
    • APA

      Cianni, L., Satori, G. R., Rosini, F., De Vitta, D., Pires, G. L. de P., Lopes, B. R., et al. (2018). Leveraging the cruzain S3 subsite to increase affinity for reversible covalent inhibitors. Bioorganic Chemistry, 285-292. doi:10.1016/j.bioorg.2018.04.006
    • NLM

      Cianni L, Satori GR, Rosini F, De Vitta D, Pires GL de P, Lopes BR, Leitão A, Burtoloso ACB, Montanari CA. Leveraging the cruzain S3 subsite to increase affinity for reversible covalent inhibitors [Internet]. Bioorganic Chemistry. 2018 ; 285-292.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.bioorg.2018.04.006
    • Vancouver

      Cianni L, Satori GR, Rosini F, De Vitta D, Pires GL de P, Lopes BR, Leitão A, Burtoloso ACB, Montanari CA. Leveraging the cruzain S3 subsite to increase affinity for reversible covalent inhibitors [Internet]. Bioorganic Chemistry. 2018 ; 285-292.[citado 2024 out. 03 ] Available from: https://doi.org/10.1016/j.bioorg.2018.04.006
  • Source: Chemical Biology and Drug Design. Unidade: IQSC

    Subjects: BIOQUÍMICA, BIOLOGIA

    Versão PublicadaHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Wiley-Blackwell Publishing, Inc. Disponível em: https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf. Acesso em: 03 out. 2024. , 2017
    • APA

      Chemical Biology and Drug Design. (2017). Chemical Biology and Drug Design. Chemical Biology and Drug Design. Hoboken: Wiley-Blackwell Publishing, Inc. Recuperado de https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf
    • NLM

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2017 ;[citado 2024 out. 03 ] Available from: https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf
    • Vancouver

      Chemical Biology and Drug Design [Internet]. Chemical Biology and Drug Design. 2017 ;[citado 2024 out. 03 ] Available from: https://repositorio.usp.br/directbitstream/7d5f144e-eeb7-48f5-b01d-9a5c9bacb874/P17700.pdf

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024